CONCORD, NH – New Hampshire will be awarded federal grants from the U.S. Department of Health and Human Services to expand access to medication-assisted treatment and to enhance the State’s collection and use of drug overdose data.
Administered by the Substance Abuse and Mental Health Services Administration (SAMHSA) and the Centers for Disease Control and Prevention (CDC), New Hampshire will receive an estimated $1 million for medication-assisted treatment and approximately $250,000 for drug overdose data surveillance. The New Hampshire Department of Health and Human Services will be notified of the exact figure for the grants when it receives an official Notice of Award from the federal government, which it has not yet received.
Efforts in New Hampshire to expand access to medication-assisted treatment for patients in New Hampshire have been ongoing, including efforts to help recruit and contract with physician practices to develop or enhance their capacity to provide medication-assisted treatment.
The grant to expand medication-assisted treatment will go to Manchester Community Health Center and Harbor Homes Harborcare Health and Wellness Center to expand their provision of medication-assisted treatment services and partner with local substance use disorder and recovery support providers to provide patients access to care planning, coordination, and delivery of care.
The drug overdose data surveillance grant will support data analysts in the Division of Public Health Services and the Office of Medical Examiner to enhance the State’s collection and use of drug overdose data. A committee is expected to be formed to analyze data and trends in the opioid epidemic to ensure that resources are being allocated as effectively as possible, which will help build on the efforts supported by this grant.
The U.S. Department of Health and Human Services will provide up to $11 million to 11 states through Medication-Assisted Treatment Prescription Drug Opioid Addiction Grants and $4.27 million in funds to 12 states through the Enhanced State Surveillance of Opioid-Involved Morbidity and Mortality program.
